Provided by Tiger Trade Technology Pte. Ltd.

Goldman Sachs Future Health Care Equity ETF

36.52
-0.6170-1.66%
Post-market: 37.140.6170+1.69%16:10 EDT
Volume:13
Turnover:505
Market Cap:19.17M
PE:- -
High:36.52
Open:37.14
Low:36.52
Close:37.14
52wk High:38.66
52wk Low:31.32
Shares:525.00K
Float Shares:525.00K
Volume Ratio:0.02
T/O Rate:0.00%
Dividend:0.11
Dividend Rate:0.31%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
8 hours ago

Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
9 hours ago

Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026

GlobeNewswire
·
9 hours ago

Sector Update: Healthcare

MT Newswires Live
·
10 hours ago

Trump Medicare Drug Pricing Model May Apply to Only Four Companies After Exemptions

Reuters
·
11 hours ago

Merck's Tulisokibart Data From Hidradenitis Suppurativa Trial Looks Solid, UBS Securities Says

MT Newswires Live
·
13 hours ago

Eli Lilly's Obesity Data Support Broader Portfolio Beyond Tirzepatide, UBS Says

MT Newswires Live
·
13 hours ago

Health Insurers Fall After UnitedHealthcare, Aetna Announce 2027 Plan Designs

Reuters
·
13 hours ago

Eli Lilly (LLY) Ends Cancer Development Deal with Foghorn Therapeutics

TIPRANKS
·
Yesterday

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (OtherSNYNF), Sagimet Biosciences, Inc. Class A (SGMT) and Eli Lilly & Co (LLY)

TIPRANKS
·
Yesterday

Seegnal Extends Private Placement to Strengthen Capital for Clinical Decision Support Growth

TIPRANKS
·
Yesterday

AIM ImmunoTech Spotlights Growing Attention Around Ampligen® Pancreatic Cancer Strategy as DURIPANC Advances Toward Topline Data

GlobeNewswire
·
Yesterday

Veeva supporting transformation of medicine through AI, Barron’s reports

TIPRANKS
·
Yesterday

Guardant Health price target raised to $200 from $190 at Guggenheim

TIPRANKS
·
Yesterday

Foghorn Therapeutics Slashes Jobs After Ending Cancer Drug Trials with Ely Lilly

Dow Jones
·
Yesterday

Jefferies Adjusts Price Target on Merck & Co to $177 From $175, Keeps Buy Rating

MT Newswires Live
·
Yesterday

Coty Names Kara Langan General Manager, U.S. Consumer Beauty Division

Reuters
·
Yesterday

Lilly Says Foundayo Cuts Predicted 10-Year Type 2 Diabetes Risk 57% in Attain-1 Post-Hoc Analysis

Reuters
·
Yesterday

Eli Lilly - Foundayo 17.2 Mg Associated with 57% Reduction in Diabetes Risk, 18% in Cardiovascular Risk Versus Placebo

Reuters
·
Yesterday

Eli Lilly - Foundayo Associated with Reduced Predicted Long-Term Risk of Type 2 Diabetes and Cardiovascular Disease

THOMSON REUTERS
·
Yesterday